TSH on Apr, 13 2026 said its group will undertake three related-party transactions aimed at enlarging its oil-palm footprint in Central Kalimantan, Indonesia.

PT Sawit Prima Mas Nusantara (PT SPMN), a 90 per cent-owned indirect subsidiary of TSH, has signed a conditional agreement to buy 2,499,999 shares – equal to 99.99996 per cent – of PT Daya Agro Sawita (PT DAS) from Bambang Suparno for IDR5.50 billion (about S$0.37 million). A 10 per cent deposit is payable immediately, with the balance due within 90 days after all conditions are met.

Separately, PT Mitra Jaya Cemerlang (PT MJC), another TSH-linked entity, will purchase the remaining single share in PT DAS from Agus Mahdar for IDR2,200, a token amount of roughly S$0.0003 million. On completion, the TSH group will own 100 per cent of PT DAS, which controls 1,140 ha of land, 787 ha of which is plantable and located about 40 km from PT SPMN’s existing mill.

In the third deal, TSH has agreed to buy all issued shares of Malaysia-incorporated Konsep Majureka Sdn Bhd (KMSB) from two related vendors for a total consideration of S$10.2 million. The price comprises S$6.4 million for the shares and the assumption of about S$3.8 million of liabilities owed to the vendors. KMSB owns 90 per cent of PT Kusuma Mandiri Sejahtera (PT KMS), which holds 9,842 ha of land – 3,512 ha of which are plantable under an ongoing land-use permit (HGU) application – situated roughly 55 km from TSH’s PT MJC estates.

All payments will be funded with internal resources. The transactions are expected to close in the second half of 2026 after customary due-diligence and regulatory clearances. TSH said the deals are not subject to shareholder or regulatory approvals and will not materially affect its 2026 earnings, net assets, or gearing, though they are anticipated to enhance long-term plantation scale and operational efficiency.

The board, with the interested vendors abstaining, and the company’s audit committee have both concluded that the acquisitions are fair, executed on normal commercial terms and in the best interests of TSH and its minority shareholders.